Image
🏄 What's your Mission? PyndanEX™ 🔎 Discover The Possibilities We're Spreading Results! powered by Surfing Waves We're Spreading Result Allocated Industries\ Dimdotworks, Inc. Intellectual Property Allocated Industries Disclaimer Privacy Policy                                            Is An Equal Opportunity Partnership Endeavor To Where It Matters priceages.com Ticker Tape by TradingView Allocated Industries 2021© Priceages Magazine ALL RIGHTS RESERVED HC ALLOCATED INDUSTRIES CORPORATION | ALL RIGHTS RESERVED “ᴏᴜʀ ғɪʀᴍ ʙᴇʟɪᴇғ ᴛʜᴀᴛ ᴠᴀʟᴜᴇ ʜᴀs ǫᴜᴀʟɪᴛɪᴇs ᴛʜᴀᴛ ғᴀʀ ᴇxᴄᴇᴇᴅ ᴀɴʏ ʙᴀʀʀɪᴇʀs ᴏɴᴇ ᴄᴀɴ ᴇғғᴇᴄᴛɪᴠᴇʟʏ ᴄᴏɴᴛʀᴏʟ ᴛʜᴇɪʀ ᴇᴄᴏɴᴏᴍɪᴄ ᴅᴇsᴛɪɴʏ ʙʏ ғᴏʀᴍɪɴɢ ʟɪғᴇ ʟᴏɴɢ ᴡᴏʀᴋɪɴɢ ʜᴀʙɪᴛs, ᴛᴇᴄʜɴɪᴄᴀʟ sᴋɪʟʟs, ᴀɴᴅ ᴇᴅᴜᴄᴀᴛɪᴏɴᴀʟ ʙᴜsɪɴᴇss ᴠᴀʟᴜᴇs sɪᴍᴜʟᴛᴀɴᴇᴏᴜs ᴛᴏ ᴇɴʀɪᴄʜɪɴɢ ᴛʜᴇ ᴄᴏᴍᴍᴜɴɪᴛʏ ᴀʀᴏᴜɴᴅ ᴛʜᴇᴍ… “ᴇɴᴠɪsɪᴏɴ ᴛʜᴇ ᴡᴏʀʟᴅ; ᴄᴏᴏʀᴅɪɴᴀᴛᴇ ʏᴏᴜʀ ғᴜᴛᴜʀᴇ”

NASH biotech Terns Pharmaceuticals files for a $100 million IPO

Terns Pharmaceuticals, a Phase 2 biotech developing small molecule therapies for NASH, filed on Friday with the SEC to raise up to $100 million in an initial public offering. The company's most advanced program is TERN-101, a liver-distributed, non-bile acid

source https://www.nasdaq.com/articles/nash-biotech-terns-pharmaceuticals-files-for-a-%24100-million-ipo-2021-01-15

Popular posts from this blog